Cardiovascular Risk in Men: The Labs That Could Save Your Life

Written by Kristy Beard, MSN, APRN, FNP-C — Board-Certified Family Nurse Practitioner and Founder of Elevate Health and Wellness, serving patients across the Gulf Coast in Gautier, MS and Foley, AL.

The Cardiovascular Burden on Gulf Coast Men

Heart disease is the leading cause of death in men in the United States — and on the Gulf Coast, the burden is disproportionately severe. Mississippi and Alabama consistently rank among the states with the highest rates of cardiovascular mortality, driven by a convergence of risk factors including above-average rates of obesity, hypertension, type 2 diabetes, smoking, and physical inactivity. According to the Centers for Disease Control and Prevention, the age-adjusted heart disease death rate in Mississippi is approximately 30% above the national average. For Gulf Coast men, cardiovascular risk assessment is not an optional wellness consideration — it is a clinical necessity.

Why Standard Cholesterol Testing Is Not Enough

The standard lipid panel — total cholesterol, LDL, HDL, and triglycerides — captures important cardiovascular risk information but misses clinically significant factors that determine actual risk. Two men with identical LDL cholesterol values can have dramatically different cardiovascular risk profiles based on LDL particle number, particle size, the presence of inflammatory biomarkers, and metabolic factors including insulin resistance and homocysteine elevation. At Elevate, Kristy Beard, MSN, APRN, FNP-C builds cardiovascular risk panels that go beyond the standard lipid screen to capture the full picture.

The Complete Cardiovascular Lab Panel for Men at Risk

A comprehensive cardiovascular risk evaluation at Elevate includes the standard lipid panel as a foundation. The NMR LipoProfile adds LDL particle number and size — the most predictive lipid markers for cardiovascular events. High-sensitivity CRP measures arterial inflammation — an independent predictor of cardiovascular risk that is not captured by lipid testing. Homocysteine evaluates a pro-inflammatory, pro-thrombotic amino acid that rises with B-vitamin deficiency and independently predicts cardiovascular and stroke risk. Lipoprotein(a) — Lp(a) — is a genetically determined lipid particle that significantly elevates cardiovascular risk in carriers and is not evaluated on standard panels. HbA1c and fasting insulin identify insulin resistance and early glucose dysregulation — both powerful independent cardiovascular risk factors. BNP or NT-proBNP evaluates cardiac wall stress. And for men over 50 with multiple risk factors, vascular screening ultrasound adds structural assessment of carotid and aortic disease.

Testosterone and Cardiovascular Risk

Testosterone deficiency in men is an independent risk factor for cardiovascular disease — associated with increased visceral adiposity, insulin resistance, dyslipidemia, and endothelial dysfunction. Research published in the European Heart Journal demonstrates that low testosterone is associated with significantly increased cardiovascular mortality in men over 40. Including testosterone assessment alongside cardiovascular markers provides a more complete and actionable picture of metabolic and cardiac risk than either evaluation alone.

Ready for a comprehensive cardiovascular risk evaluation? Visit our Men's Health and Lab pages at Elevate in Gautier, MS and Foley, AL.

Sources: CDC. Heart Disease in Men. cdc.gov. | European Heart Journal. Testosterone and Cardiovascular Mortality. academic.oup.com. | American Heart Association. Advanced Lipid Testing. heart.org.

This article is written by Kristy Beard, MSN, APRN, FNP-C, board-certified Family Nurse Practitioner and founder of Elevate Health and Wellness. Information provided is for educational purposes only and does not constitute medical advice. Please consult a licensed healthcare provider for personalized care.